UPDATE: Credit Suisse Downgrades Ariad Pharmaceuticals As Launch Metrics Are Still Weak
December 11, 2014 at 08:06 AM EST
In a report published Thursday, Credit Suisse analyst Jason Kantor downgraded the rating on Ariad Pharmaceuticals (NASDAQ: ARIA) from ...